Descrizione Clinica
Other disorders Valerian dispert 60cpr riv45m Valerian Dispert
VALERIANA DISPERT 45 MG STATEMENTS
active ingredients
A coated tablet contains: Active ingredient: Valerian root dry extract mg 45 prepared with ethanol 70 % v/v ( Valerian root ratio: extract of 3–6: 1). Excipients with known effects: lactose and sucrose. For the full list of excipients, see paragraph 6.1.Excellent
Dextrine, microcrystalline cellulose, monohydrate lactose, 4000 macrogol, anidra colloidal silica, magnesium stearate, lacquer, hypromellose, talc, magnesium light oxide, arabic rubber, sucrose, K25 povidone, 6000 macrogol, titanium dioxide, sodium carmellose, white wax, carnauba.Therapeutic indications
Clear sedative, also to favor the night rest.Contraindications
Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1. Generally contraindicated during pregnancy and nursing.Population
Population Children: 1–2 tablets coated twice daily, adults: 1–3 tablets coated three times a day. Method of administration The coated tablets should be swallowed without chewing.Conservation
Do not store at temperature above 30 ° C.Warnings
Do not exceed the recommended doses. Consult your doctor if your symptoms persist for more than 2 weeks or worsen during treatment. Valeriana DISPERT contains lactose: Patients with rare hereditary problems of galactose intolerance, lactase deficiency, or glucose–galactose mal absorption, should not take this medicine. Valeriana DISPERT contains sucrose: Patients with rare hereditary problems of fructose intolerance, glucose–galactose mal absorption, or isomaltase sucrasis failure, should not take this medicine. Keep the medicine out of reach of children.Interactions
No interactions have been reported. The patient is however invited to ask the doctor if he is taking other drugs.Effects
No undesirable effects are known for the use of the medicinal product under the recommended conditions and for short periods of time. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.agenziafarmaco.gov.it/it/responsabili.Overdosing
The root of valerian at a dose of about 20 g causes slight symptoms (affactication, abdominal cramps, slight vertigo sensation, thoracic oppression, tremors to the hands and midriasis) that disappear in 24 hours. If the symptoms appear, proper treatment must be established.Since no data are available on use during pregnancy and nursing, precautionary, it is generally not recommended to use it. No adverse effects were reported as a result of the common use of valerian root as a medicinal product, but adequate experimental data is lacking.
Source: Farmadati
